Tiger Pharmaceuticals: Announcement on the progress of share repurchases
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Hangzhou Tigermed Consulting: Announcement of the implementation of equity distribution in 2023.
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Hangzhou Tigermed Consulting: Announcement about the progress of stock repurchase.
Hangzhou Tigermed Consulting: Announcement on the initial repurchase of company shares
Hangzhou Tigermed Consulting: Announcement on additional pledges and partial share repurchases and cancellation of pledges for shareholders holding 5% or more of shares
Hangzhou Tigermed Consulting: Announcement on the completion of cancellation of share repurchases and changes in shares
Hangzhou Tigermed Consulting: Repurchase Report
Hangzhou Tigermed Consulting: Announcement on the shareholding status of the top ten A-share shareholders and the top ten A-share shareholders with unlimited sales conditions for the repurchase of part of the company's shares
Tiger Pharmaceuticals: Announcement on Adjusting the Company's Share Repurchase Plan
Tiger Pharmaceuticals: Announcement on terminating the 2022 A-share Restricted Stock Incentive Plan
Tiger Pharmaceuticals: Legal Opinion on the Termination of the 2022 A-Share Restricted Stock Incentive Plan and the Cancellation of Restricted Shares
Tiger Pharmaceuticals: 2023 Profit Distribution Plan
Tiger Pharmaceuticals: Announcement on the shareholding status of the top ten A-share shareholders and the top ten A-share shareholders with unlimited sales conditions for the repurchase of part of the company\'s shares
Tiger Pharmaceuticals: Announcement on the plan to repurchase the company\'s shares
Tiger Pharmaceuticals: Announcement on supplementary pledges for some shares of shareholders holding 5% or more of the shares
Tiger Pharmaceuticals: Announcement on supplementary pledges for some shares of shareholders holding 5% or more of the shares
Tiger Pharmaceuticals: 300347 Announcement on the controlling shareholder\'s commitment not to reduce the company\'s share holdings
No Data
No Data